Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Gross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Ocular Therapeutix (OCUL) Other Gross PP&E Adjustments (2016 - 2026)

Ocular Therapeutix has reported Other Gross PP&E Adjustments over the past 14 years, most recently at -$10.1 million for Q1 2026.

  • For Q1 2026, Other Gross PP&E Adjustments fell 7.67% year-over-year to -$10.1 million; the TTM value through Mar 2026 reached -$10.1 million, down 7.67%, while the annual FY2025 figure was $40.3 million, 135.88% up from the prior year.
  • Other Gross PP&E Adjustments for Q1 2026 was -$10.1 million at Ocular Therapeutix, down from $40.3 million in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $40.3 million in Q4 2025 and troughed at -$10.1 million in Q1 2026.
  • A 5-year average of -$1.2 million and a median of -$7.9 million in 2024 define the central range for Other Gross PP&E Adjustments.
  • Biggest five-year swings in Other Gross PP&E Adjustments: plummeted 60.4% in 2023 and later surged 135.88% in 2025.
  • Year by year, Other Gross PP&E Adjustments stood at $10.3 million in 2022, then skyrocketed by 46.32% to $15.1 million in 2023, then increased by 13.37% to $17.1 million in 2024, then surged by 135.88% to $40.3 million in 2025, then crashed by 125.15% to -$10.1 million in 2026.
  • Business Quant data shows Other Gross PP&E Adjustments for OCUL at -$10.1 million in Q1 2026, $40.3 million in Q4 2025, and -$8.7 million in Q3 2025.